Trial intelligence / Profile preview

STAR

2016-001618-18Phase 4Completed

Sponsor
Centre hospitalier universitaire de Toulouse
Start
Jun 2016
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in rheumatoid arthritis (RA) comparing Progressive prednisone taper with Hydrocortisone replacement strategy (2 arms). Primary endpoint: Proportion of patients who could withdraw from prednisone and hydrocortisone. Started Jun 2016; status: completed.

02

Drugs

prednisonehydrocortisone
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on 2016-001618-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-001618-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call